No impact of disseminated intravascular coagulation in kidney donors on long-term kidney transplantation outcome: A multicenter propensity-matched study.


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
02 2019
Historique:
received: 08 12 2017
revised: 14 06 2018
accepted: 24 06 2018
pubmed: 8 7 2018
medline: 23 4 2020
entrez: 8 7 2018
Statut: ppublish

Résumé

The diagnosis of disseminated intravascular coagulation (DIC) is often considered to be a contraindication to organ donation. The aim of this study was to evaluate the impact of DIC+ donors on kidney recipient (KR) evolution. We identified 169 KRs with DIC+ donation after brain death donors between January 1996 and December 2012 in 6 French transplant centers. Individuals were matched using propensity scores to 338 recipients with DIC- donors according to donor age and sex, whether expanded criteria for the donor existed, graft year, and transplantation center. After kidney transplantation, delayed graft function was observed in 28.1% of DIC+ KRs and in 22.8% of DIC- KRs (NS). Renal allograft survival at 1, 5, and 10 years was 94.5%, 89.3%, and 73.9% and 96.2%, 90.8%, and 81.3% in DIC+ KRs and DIC- KRs, respectively (NS). The median estimated glomerular filtration rate (eGFR) was similar between DIC+ and DIC- KRs at 3 months, 1 year, and 10 years: 45.9 vs 48.1 mL/min, 42.1 vs 43.1 mL/min, and 33.9 vs 38.1 mL/min, respectively. Delayed calcineurin inhibitor introduction or induction had no impact on delayed graft function rate or eGFR evolution at 10 years after transplantation in DIC+ KRs. Donor DIC did not seem to affect initial outcome, long-term graft function, or allograft survival.

Identifiants

pubmed: 29981217
doi: 10.1111/ajt.15008
pii: S1600-6135(22)08948-1
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

448-456

Informations de copyright

© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Auteurs

Cyril Garrouste (C)

Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Julien Baudenon (J)

Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Philippe Gatault (P)

Department of Nephrology and Clinical Immunology, CHRU de Tours, Tours, France.

Bruno Pereira (B)

Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Clermont-Ferrand, France.

Isabelle Etienne (I)

Department of Nephrology, CHRU de Rouen, Rouen, France.

Antoine Thierry (A)

Department of Nephrology Dialysis and Kidney Transplantation, CHU de Poitiers, Poitiers, France.

Nora Szlavik (N)

Pathology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Julien Aniort (J)

Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Marion Rabant (M)

Pathology Department, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Céline Lambert (C)

Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, Clermont-Ferrand, France.

Johnny Sayegh (J)

Department of Nephrology Dialysis and Kidney Transplantation, CHU d' Angers, Angers, France.

Julie Oniszczuk (J)

Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Dany Anglicheau (D)

Department of Nephrology and Kidney Transplantation, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Anne Elisabeth Heng (AE)

Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH